BackNRX Pharmaceuticals- Warrants (24/05/2026) Overview
NRX Pharmaceuticals Inc - Warrants (24/05/2026)

NRX Pharmaceuticals- Warrants (24/05/2026) Discounted Cash Flow

DCF Analysis for NRXPW.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$0.58

Current Fair Value

$0.58
3981.0% Upside

Undervalued by 3981.0% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading